Trial Profile
Bipolar depression assessment study on Tx [treatment] response
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2006
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Olanzapine
- Indications Bipolar disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 29 Aug 2006 Status change
- 10 Nov 2005 New trial record.